Traws Pharma
TRAW
56 hedge funds and large institutions have $33.6M invested in Traws Pharma in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 15 increasing their positions, 5 reducing their positions, and 5 closing their positions.
460% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 5
392% more capital invested
Capital invested by funds: $6.83M → $33.6M (+$26.8M)
200% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 5
70% more funds holding
Funds holding: 33 → 56 (+23)
0.02% more ownership
Funds ownership: 0.02% → 0.04% (+0.02%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$3.72M |
| 2 |
BlackRock
New York
|
+$3.62M |
| 3 |
Millennium Management
New York
|
+$2.84M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.29M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
+$1.32M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$514K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$106K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$61.9K |
| 4 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
-$38.9K |
| 5 |
MA
MONECO Advisors
Fairfield,
Connecticut
|
-$30.2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SPIA
51
Steward Partners Investment Advisory
New York
| $1.17K | +$1.13K | +3 | New |
|
|
LFG
52
Larson Financial Group
St Louis,
Missouri
| $1K | – | – | – |
|
|
WCM
53
Wealthcare Capital Management
Richmond,
Virginia
| $1K | +$754 | +2 | New |
|
|
MAM
54
McCarthy Asset Management
Redwood Shores,
California
| $1K | +$1.13K | +3 | New |
|
|
GCP
55
GSA Capital Partners
London,
United Kingdom
| – | -$106K | -608 | Closed |
|
|
RWG
56
Ratio Wealth Group
Denver,
Colorado
| – | -$23.3K | -133 | Closed |
|
|
BCM
57
Bayesian Capital Management
Brooklyn,
New York
| – | -$13K | -74 | Closed |
|
58
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$12K | -45 | Closed |
|
|
GG
59
Golden Green
Seneca,
South Carolina
| – | -$6K | -32 | Closed |
|
|
IF
60
Ironwood Financial
Tucson,
Arizona
| – | +$377 | +1 | New |
|
TRAW Hedge Fund Activity: Q1 2021 in Review
56 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q1 2021, worth a combined $33.6M — up 392% from $6.83M a quarter earlier.
Buyers outnumbered sellers: 28 funds opened new TRAW positions and 5 closed out — a net gain of 23 holders — while 15 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $3.72M. The largest seller was Citadel Advisors, cutting an estimated $514K.
- 56 institutional investors held Traws Pharma (TRAW) as of Q1 2021, up from 33 in Q4 2020.
- Funds reported $33.6M of Traws Pharma stock for Q1 2021, up 392% quarter-over-quarter.
- 28 funds opened new Traws Pharma positions in Q1 2021 and 5 closed out, a net change of +23 holders.
- The largest Traws Pharma buyer in Q1 2021 was Renaissance Technologies, an estimated $3.72M added.
- The largest Traws Pharma seller in Q1 2021 was Citadel Advisors, an estimated $514K sold.
Based on aggregated 13F filings for Q1 2021.